ArticleACS omega2024
Effect of PFDTS/TiO
Article in ACS omega, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Phosphogypsum (PG) constitutes a form of solid byproduct emanating from the manufacturing process of wet-process phosphoric acid. The fabrication of one metric ton of wet-process phosphoric acid entails the generation of approximately five tons of phosphogypsum, a highly prolific and economically viable waste stream. If we can effectively solve the problem of poor hydrophobicity of phosphogypsum, it is possible to replace cement and other traditional cementitious materials. In this way, we can not only improve the utilization rate of phosphogypsum but also obtain significant economic and environmental benefits. In the present investigation, hydrophobic surface coatings were synthesized and applied onto the surface of α-hemihydrate phosphogypsum (α-HPG) utilizing sol-gel processing and impregnation techniques. After hydroxylating α-HPG with alkaline solution (OH-α-HPG), titanium dioxide nanoparticles (TiO
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.